Kidney disease and cancer are frequent comorbidities that require specialized knowledge and expertise from both the nephrologist and the oncologist. Written by three pioneers in this growing subspecialty, Onco-Nephrology provides authoritative, definitive coverage of the mechanism and management of these two life-threatening diseases. This unique, single-volume resource covers current protocols and recommends management therapies to arrest kidney failure and allow oncologic treatments to continue and succeed.
1. Cover image - p. i 2. Title page - p. ii 3. Table of Contents - p. iii 4. Inside front cover - p. iii 5. Copyright - p. iii 6. Dedication - p. iii 7. Contributors - p. iii 8. Preface - p. iii 9. SECTION 1: Fluid and Electrolyte Disorders in Cancer Patients - p. iii 10. List of Illustrations - p. iii 11. List of Tables - p. iii 12. Chapter 1: Kidney function - p. iii 13. Chapter 2: Dysnatremias in cancer - p. 8 14. Chapter 3: Potassium disorders - p. 18 15. Chapter 4: Calcium and phosphorus disorders - p. 28 16. Chapter 5: Volume disorders and fluid resuscitation - p. 44 17. SECTION 2: Paraprotein-Related Kidney Diseases - p. 52 18. Chapter 6: Paraproteins - p. 52 19. Chapter 7: Cast nephropathy - p. 58 20. Chapter 8: Systemic light chain amyloidosis - p. 66 21. Chapter 9: Monoclonal immunoglobulin deposition disease - p. 75 22. Chapter 10: Fibrillary and immunotactoid glomerulonephritis - p. 84 23. SECTION 3: Hematopoietic Stem Cell Associated Kidney Disease - p. 87 24. Chapter 11: Hematopoietic cell transplant associated kidney injury - p. 87 25. Chapter 12: Sinusoidal obstruction syndrome - p. 98 26. Chapter 13: Thrombotic microangiopathy - p. 106 27. Chapter 14: Graft-versus-host disease - p. 113 28. Chapter 15: Chronic kidney disease, end-stage renal disease, and bone marrow transplant - p. 117 29. SECTION 4: Chemotherapy and Radiation Related Kidney Diseases - p. 125 30. Chapter 16: Conventional chemotherapy - p. 125 31. Chapter 17: Targeted cancer therapies (biologics) - p. 153 32. Chapter 18: Adverse kidney effects of immunotherapies - p. 165 33. Chapter 19: Chemotherapy in chronic kidney disease and dialysis - p. 182 34. Chapter 20: Radiation nephropathy - p. 196 35. SECTION 5: Paraneoplastic Glomerulopathies - p. 203 36. Chapter 21: Paraneoplastic glomerular diseases - p. 203 37. Chapter 22: Paraneoplastic glomerulonephritis - p. 212 38. Chapter 23: Hematologic malignancies - p. 218 39. Chapter 24: Cancer screening recommendations - p. 224 40. SECTION 6: Renal Tumors - p. 228 41. Chapter 25: Renal cell cancer - p. 228 42. Chapter 26: Wilms tumor and von hippel lindau disease - p. 243 43. Chapter 27: Tuberous sclerosis complex and the kidney - p. 250 44. Chapter 28: Evaluation of a renal cyst/mass - p. 258 45. SECTION 7: Acute Kidney Injury - p. 267 46. Chapter 29: Acute kidney injury incidence, pathogenesis, and outcomes - p. 267 47. Chapter 30: Tumor lysis syndrome - p. 274 48. Chapter 31: Obstructive nephropathy in cancer - p. 280 49. Chapter 32: Renal replacement therapies - p. 289 50. SECTION 8: Chronic Kidney Disease and Cancer - p. 298 51. Chapter 33: Chronic kidney disease as a complication of cancer, with special focus on kidney and urothelial tumors - p. 298 52. Chapter 34: Incidence of cancer and screening recommendations - p. 306 53. Chapter 35: Cancer in renal transplant patients - p. 313 54. SECTION 9: Kidney Infections - p. 321 55. Chapter 36: Renal infections in cancer patients - p. 321 56. SECTION 10: Infiltrative Diseases - p. 335 57. Chapter 37: Kidney disease in leukemia - p. 335 58. Chapter 38: Kidney disease in lymphoma - p. 346 59. Index - p. 354
Kidney disease and cancer are frequent comorbidities that require specialized knowledge and expertise from both the nephrologist and the oncologist. Written by three pioneers in this growing subspecialty, Onco-Nephrology provides authoritative, definitive coverage of the mechanism and management of these two life-threatening diseases. This unique, single-volume resource covers current protocols and recommends management therapies to arrest kidney failure and allow oncologic treatments to continue and succeed.
1. Cover image - p. i 2. Title page - p. ii 3. Table of Contents - p. iii 4. Inside front cover - p. iii 5. Copyright - p. iii 6. Dedication - p. iii 7. Contributors - p. iii 8. Preface - p. iii 9. SECTION 1: Fluid and Electrolyte Disorders in Cancer Patients - p. iii 10. List of Illustrations - p. iii 11. List of Tables - p. iii 12. Chapter 1: Kidney function - p. iii 13. Chapter 2: Dysnatremias in cancer - p. 8 14. Chapter 3: Potassium disorders - p. 18 15. Chapter 4: Calcium and phosphorus disorders - p. 28 16. Chapter 5: Volume disorders and fluid resuscitation - p. 44 17. SECTION 2: Paraprotein-Related Kidney Diseases - p. 52 18. Chapter 6: Paraproteins - p. 52 19. Chapter 7: Cast nephropathy - p. 58 20. Chapter 8: Systemic light chain amyloidosis - p. 66 21. Chapter 9: Monoclonal immunoglobulin deposition disease - p. 75 22. Chapter 10: Fibrillary and immunotactoid glomerulonephritis - p. 84 23. SECTION 3: Hematopoietic Stem Cell Associated Kidney Disease - p. 87 24. Chapter 11: Hematopoietic cell transplant associated kidney injury - p. 87 25. Chapter 12: Sinusoidal obstruction syndrome - p. 98 26. Chapter 13: Thrombotic microangiopathy - p. 106 27. Chapter 14: Graft-versus-host disease - p. 113 28. Chapter 15: Chronic kidney disease, end-stage renal disease, and bone marrow transplant - p. 117 29. SECTION 4: Chemotherapy and Radiation Related Kidney Diseases - p. 125 30. Chapter 16: Conventional chemotherapy - p. 125 31. Chapter 17: Targeted cancer therapies (biologics) - p. 153 32. Chapter 18: Adverse kidney effects of immunotherapies - p. 165 33. Chapter 19: Chemotherapy in chronic kidney disease and dialysis - p. 182 34. Chapter 20: Radiation nephropathy - p. 196 35. SECTION 5: Paraneoplastic Glomerulopathies - p. 203 36. Chapter 21: Paraneoplastic glomerular diseases - p. 203 37. Chapter 22: Paraneoplastic glomerulonephritis - p. 212 38. Chapter 23: Hematologic malignancies - p. 218 39. Chapter 24: Cancer screening recommendations - p. 224 40. SECTION 6: Renal Tumors - p. 228 41. Chapter 25: Renal cell cancer - p. 228 42. Chapter 26: Wilms tumor and von hippel lindau disease - p. 243 43. Chapter 27: Tuberous sclerosis complex and the kidney - p. 250 44. Chapter 28: Evaluation of a renal cyst/mass - p. 258 45. SECTION 7: Acute Kidney Injury - p. 267 46. Chapter 29: Acute kidney injury incidence, pathogenesis, and outcomes - p. 267 47. Chapter 30: Tumor lysis syndrome - p. 274 48. Chapter 31: Obstructive nephropathy in cancer - p. 280 49. Chapter 32: Renal replacement therapies - p. 289 50. SECTION 8: Chronic Kidney Disease and Cancer - p. 298 51. Chapter 33: Chronic kidney disease as a complication of cancer, with special focus on kidney and urothelial tumors - p. 298 52. Chapter 34: Incidence of cancer and screening recommendations - p. 306 53. Chapter 35: Cancer in renal transplant patients - p. 313 54. SECTION 9: Kidney Infections - p. 321 55. Chapter 36: Renal infections in cancer patients - p. 321 56. SECTION 10: Infiltrative Diseases - p. 335 57. Chapter 37: Kidney disease in leukemia - p. 335 58. Chapter 38: Kidney disease in lymphoma - p. 346 59. Index - p. 354
